Novartis' expenditure on research and development 2004-2019

This statistic shows the expenditure on research and development of Swiss-based pharmaceutical company Novartis from 2004 to 2019. Novartis AG is one of the world's largest pharma companies. In 2019, Novartis spent approximately 9.4 billion U.S. dollars on research and development.

Novartis AG's expenditure on research and development from 2004 to 2019

Expenditure in billion U.S. dollars
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

January 2020

Region

Worldwide

Survey time period

2004 to 2019

Supplementary notes

This statistic was assembled from several annual reports.
* With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015.
** During 2019, eye care division Alcon was spun off and became an own company. Thus, Alcon's expenses are not included.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Novartis"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.